The steps, described in detail below, are (1) cohort identification, (2) effectiveness estimation for clinical outcomes of interest, (3) cost estimation, (4) base-case analysis, and (5) sensitivity analyses
Before taking this medicine You should not use this medicine if you are allergic to semaglutide or any other ingredients in this medicine, or if you have: multiple endocrine neoplasia type 2 (tumors in your glands)
This technology can identify compounds by their exact molecular weight and fragmentation pattern
In addition to managing diabetes, tirzepatide helps people lose weight, which can have a positive impact on kidney health
PubMed laboratory research record [PMID: 39345280] PubMed record related to this compound for laboratory literature review